Cartesian Therapeutics, Inc. (RNAC) insider trading

By person

17 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Timothy A Springer

Director

—

9,302,798

$63.44M

+8.8%

Murat Kalayoglu

10% owner

—

5,824,838

$39.72M

+15.1%

Elizabeth Hoge

10% owner

—

5,313,261

$36.23M

+16.6%

Carsten Brunn

President and CEO

—

323,530

$2.21M

+97.4%

Blaine Davis

Chief Financial Officer

—

121,220

$826.68K

+50.0%

Emily English

Chief Operations Officer

—

94,226

$642.59K

+415.7%

Christopher M Jewell

Chief Scientific Officer

—

62,490

$426.16K

+140.9%

Metin Kurtoglu

Chief Technology Officer

—

62,258

$424.58K

+22.0%

Milos Miljkovic

Chief Medical Officer

—

58,820

$401.13K

+221.9%

Timothy C Barabe

Director

—

56,966

$388.49K

+161.7%

Michael Singer

Director

—

49,578

$338.11K

−58.6%

Carrie Smith Cox

Director

—

15,629

$106.59K

+20.0%

Patrick J Zenner

Director

—

12,974

$88.48K

+66.9%

Nishan M DeSilva

Director

—

11,366

$77.51K

+84.3%

Kemal Malik

Director

—

11,133

$75.92K

+87.6%

June Ann Seymour

Chief Accounting Officer

—

6,500

$44.33K

—

Adrian Ion Bot

Director

—

5,800

$39.55K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Cartesian Therapeutics, Inc.

What the insiders did No buying or selling

By person